-
Mashup Score: 8Scientists explore new mechanisms to combat glioblastoma - 7 month(s) ago
Glioblastoma is the most common and aggressive type of primary brain tumor, with an average survival rate of 15 months, according to the Centers for Disease Control and Prevention. While glioblastoma …
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 5
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, Oncologists1Tweet-
Arming natural killer cells with interleukin-21 endows them with enhanced and long-lasting anti-tumor activity against #glioblastoma stem cell-like cells, according to new research. https://t.co/V21lTZXU5c https://t.co/L7FUI6poXj
-
-
Mashup Score: 5
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, Oncologists1Tweet-
Arming natural killer cells with interleukin-21 endows them with enhanced and long-lasting anti-tumor activity against #glioblastoma stem cell-like cells, according to new research. https://t.co/V21lTZXU5c https://t.co/L7FUI6poXj
-
-
Mashup Score: 2Informed Consent from Patients With Glioblastoma Is a ‘Big Thing’ - 10 month(s) ago
For patients with glioblastoma, collecting information about their disease and treatment options is important before providing informed consent.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
After receiving a diagnosis of #Glioblastoma, obtaining proper information and education about the disease and treatment options is key before providing doctors with informed consent, said Dr. Stephanie E. Weiss of @FoxChaseCancer. https://t.co/AI2J9yLTLy
-
-
Mashup Score: 4Paxalisib May Improve Survival in Some With Glioblastoma - 10 month(s) ago
Results from a phase 2/3 study demonstrated that paxalisib led to a 3.8-month survival improvement in some patients with glioblastoma.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Certain patients with #glioblastoma who received paxalisib during a phase 2/3 trial experienced improved survival by 33%, an expert said in a news release. https://t.co/COwJg73HpC
-
-
Mashup Score: 2Informed Consent from Patients With Glioblastoma Is a ‘Big Thing’ - 10 month(s) ago
For patients with glioblastoma, collecting information about their disease and treatment options is important before providing informed consent.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
After receiving a diagnosis of #Glioblastoma, obtaining proper information and education about the disease and treatment options is key before providing doctors with informed consent, said Dr. Stephanie E. Weiss of @FoxChaseCancer. https://t.co/AI2J9yLTLy
-
-
Mashup Score: 7Using AI, researchers pioneer a potential new immunotherapy approach for treating glioblastoma - 10 month(s) ago
In an innovative study of glioblastoma, scientists used artificial intelligence (AI) to reprogram cancer cells, converting them into dendritic cells (DCs), which can identify cancer cells and direct other …
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet-
Using AI, researchers pioneer a potential new immunotherapy approach for treating #glioblastoma @KeckSchool_USC https://t.co/2O7KsjAHBK
-
-
Mashup Score: 3Paxalisib May Improve Survival in Some With Glioblastoma - 11 month(s) ago
Results from a phase 2/3 study demonstrated that paxalisib led to a 3.8-month survival improvement in some patients with glioblastoma.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Certain patients with #glioblastoma who received paxalisib during a phase 2/3 trial experienced improved survival by 33%, an expert said in a news release. https://t.co/COwJg73HpC
-
-
Mashup Score: 0
The International Journal of Cancer is a cancer journal from the Union for International Cancer Control covering experimental and clinical cancer research.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Oncologists1Tweet-
NOW ONLINE Targeting IKCa and BKCa calcium-activated potassium channels can radiosensitize and immobilize #glioblastoma cells, potentially offering a new treatment approach 🔓OPEN ACCESS ➡️https://t.co/EMRINQTOGj https://t.co/Yuexjg8qSD
-
-
Mashup Score: 1About the Phase 1/2 Study of IGV-001 in Glioblastoma - 1 year(s) ago
Deric Park, MD, discusses a phase 1/2 study of IGV-001, a novel treatment for glioblastoma.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet-
in this video, Deric Park, MD, discusses a phase 1/2 study of IGV-001, a novel treatment for #glioblastoma. https://t.co/lUKBugfQvQ
-
Scientists explore new mechanisms to combat #glioblastoma @northwesternu @cell_metabolism @jclinicalinvest @NatureComms https://t.co/bu3udO4pYg